DIABETICO
DIAGNOSTICS
A New Era of Precision Medicine for Type-1 Diabetes (T1D)
9M
children & adults have T1 diabetes
38%
of newly diagnosed T1D patients are under 20
175,000
deaths per year due to T1D & rising 3% yearly
Alleviate the burden.
Diabetico is developing an innovative and unique proprietary test that, on its own, will have a high T1D prediction accuracy. Our single test will replace 3 expensive tests resulting in significant cost savings for the payer and patients.
